Quick Answer
BOSTON SCIENTIFIC CORP reported Cash and Equivalents of $1.97 billion for fiscal year 2025.
BOSTON SCIENTIFIC CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.97B | +374.6% |
| 2024 | $414.00M | -52.1% |
| 2023 | $865.00M | -6.8% |
| 2022 | $928.00M | -51.8% |
| 2021 | $1.93B | +11.0% |
| 2020 | $1.73B | +699.1% |
| 2019 | $217.00M | +48.6% |
| 2018 | $146.00M | -22.3% |
| 2017 | $188.00M | -4.1% |
| 2016 | $196.00M | -38.6% |
| 2015 | $319.00M | -45.7% |
| 2014 | $587.00M | +170.5% |
| 2013 | $217.00M | +4.8% |
| 2012 | $207.00M | -22.5% |
| 2011 | $267.00M | +25.4% |
| 2010 | $213.00M | -75.3% |
| 2009 | $864.00M | -47.3% |
| 2008 | $1.64B | +13.0% |
| 2007 | $1.45B | -12.9% |
| 2006 | $1.67B | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.27B | -49.0% | +138.8% |
| June 30, 2025 | $534.00M | -81.7% | -26.3% |
| March 31, 2025 | $725.00M | -68.9% | +75.1% |
| December 31, 2024 | $414.00M | -52.1% | -83.5% |
| September 30, 2024 | $2.50B | +162.8% | -14.1% |
| June 30, 2024 | $2.91B | +583.8% | +25.1% |
| March 31, 2024 | $2.33B | +308.6% | +169.2% |
| December 31, 2023 | $865.00M | -6.8% | -9.1% |
- BOSTON SCIENTIFIC CORP showed an increase of +374.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2025 period, BOSTON SCIENTIFIC CORP’s cash and equivalents has grown by 17.8% (from $1.67 billion to $1.97 billion).
- The most recent figure is from BOSTON SCIENTIFIC CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: